Maintaining Strategy to Deliver Volumetric Growth
Adjusted EBITDA - Continuing Operations (twelve months ended)
($ in thousands)
Net income attributable to Albemarle Corporation
Depreciation and amortization
Non-recurring and other unusual items (excluding items
associated with interest expense)
Interest and financing expenses
Income tax expense
Non-operating pension and OPEB items
Adjusted EBITDA
Net sales
Adjusted EBITDA margin
Twelve Months Ended
$
Jun 30, 2022
263,551
Sep 30, 2022
Dec 31, 2022
Mar 31, 2023
$
1,553,547
$
2,689,816
$
3,675,013
$
267,884
283,515
300,841
321,538
Jun 30, 2023
3,918,283
343,630
885,605
215,768
28,671
(14,691)
198,217
79,685
104,240
122,973
121,916
106,084
69,902
381,510
390,588
587,021
540,990
(78,196)
(77,752)
(57,032)
(51,151)
(45,501)
$
1,488,431 $
2,460,828 $
3,475,857 $
4,639,646 $
5,061,703
$
4,332,091
$ 5,593,330 $
7,320,104 $ 8,772,628
$
9,663,225
34 %
44 %
47 %
53 %
52%
See above for a reconciliation of adjusted EBITDA and pro-forma adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable
financial measure calculated and reported in accordance with GAAP.
See above for a reconciliation of pro-forma net sales, the non-GAAP financial measure, to net sales, the most directly comparable financial measure calculated and reported in accordance with GAAP.
AALBEMARLE 23View entire presentation